Ukrliv oral suspension 250mg/5ml jar 40ml

Active ingredient: ursodeoxycholic acid;

5 ml of suspension contain ursodeoxycholic acid 250 mg;

Excipients: microcrystalline cellulose-sodium carboxymethylcellulose, benzoic acid (E 210), xylitol, glycerin, sodium saccharin, sodium chloride, citric acid monohydrate, sodium, lemon flavor, purified water.

• Hypersensitivity to bile acids or to any of the excipients.
• Acute cholecystitis or acute cholangitis.
• Biliary obstruction (blockage of the common bile duct or ducts).
• Frequent attacks of biliary (hepatic) colic.
• The presence of radiopaque calcified gallstones.
• The contractility of the gallbladder is impaired.
• Unsuccessful outcome of portoenterostomy or lack of adequate biliary outflow in children with biliary atresia.

To administer the required dose using a syringe

1. Before opening the bottle, the suspension must be shaken.
2. Next, you need to pour a small amount of suspension into a measuring spoon.
3. Draw a little more suspension into the syringe than needed.
4. Press the syringe plunger with your finger to remove air bubbles from the withdrawn suspension.
5. Check the volume of suspension in the syringe and adjust if necessary.
6. Carefully insert the contents of the syringe directly into the child’s mouth.

Do not draw the syringe directly from the vial. Do not pour unused suspension from the measuring spoon or syringe back into the vial.

Pregnant women

Should not be used.

Children

Apply to children from 1 month of age.

Drivers

Does not affect.

Overdose may cause diarrhea. Overdose is unlikely, as the absorption of ursodeoxycholic acid decreases with increasing dose and most of it is excreted in the feces.

In case of diarrhea, the dose should be reduced; if diarrhea persists, therapy should be discontinued.

No specific countermeasures are necessary; the effects of diarrhea should be treated symptomatically, maintaining fluid and electrolyte balance.

Gastrointestinal: loose stools or diarrhea, severe pain in the right upper abdomen.

Liver and gallbladder: calcification of gallstones, decompensation of liver cirrhosis, which partially regressed after discontinuation of treatment.

Estrogen hormones, as well as drugs to reduce cholesterol concentration in the blood, can increase the secretion of cholesterol by the liver and, thus, contribute to the formation of gallstones, which is the opposite effect of ursodeoxycholic acid, which is used to dissolve them.

Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.

After opening the bottle or jar, store the drug for no more than 4 months.

Shelf life – 2 years.